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A new property of the presequence of the mitochondrtal precursor protem cytochrome oxidase subunit IV is presented. This mttochondrial 
presequence induces mterbilayer contacts between large umlamellar vestcles consisting of phosphatidylchohne and cardiohpm. The presequence- 
vestcle aggregates can be dtssoctated by applymg a membrane potential across the bilayers (negative inside). These effects requtre the presence of 
cardiohpm and are not observed for other negatively charged phosphohptds. We propose a role for the presequence in the formatton and dtssociatton 
of mttochondrtal contact sites 
Mitochondrial presequence: Membrane potential: Membrane contact; Cardtohpm 
1. INTRODUCTION 
Most mitochondrial proteins are synthesized in the 
cytosol as precursor proteins with an amino-terminal, 
20-80 amino acid extension peptide, the presequence. 
Presequences do not share primary structure homology, 
but are amphipatic and contain several positively 
charged and few, if any. negatively charged residues 
[1,2]. Their common structural motive appears to be an 
amphiphilic a-helix [224]. They are required for the im- 
port of precursor proteins into mitochondria and are 
proposed to be involved in different steps in the process. 
Presequences contain the information to target attached 
proteins to mitochondria [5,6] where they are supposed 
to bind to the ‘presequence receptor’ MOM19 [7]. Prese- 
quence-specific cytosolic protein factors seem to partic- 
ipate in this process [8,9]. A 50 kDa protein, referred to 
as ‘presequence binding factor’ (PBF) [lo] and a 28 kDa 
protein, designated ‘targeting factor’ [l 1] have been pu- 
rified. For protein translocation across the inner mito- 
chondrial membrane a membrane potential (dY) across 
the inner membrane is required [12-l 51. It has been 
demonstrated that the membrane potential (negative 
inside) is needed for the translocation of only the prese- 
quence. and not the mature region, possibly via an elec- 
trophoretic effect [l&l 81. Once the precursor protein 
has reached the mitochondrial matrix, the presequence 
is proteolytically removed [ 191. Several biophysical 
studies revealed that presequences interact strongly with 
model membranes, with a preference for negatively 
charged phospholipids [3,20-251 and it has been sug- 
gested that these interactions are important for the im- 
port process. 
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Import into the mitochondrial matrix occurs at con- 
tact sites between the inner and outer membrane [ 16,261. 
Recent studies suggest that mitochondrial contact sites 
are highly dynamic [27730]. A model was proposed. 
involving the precursor protein reaching the intermem- 
brane space, after passing the outer membrane, and 
subsequently engaging the inner membrane [29]. This 
raises the question of the mechanism of the dynamic 
contact formation. One possibility is that the prese- 
quence could induce membrane contacts and that the 
membrane potential plays a role in this process. To 
address this question, studies were carried out with a 
synthetic presequence, corresponding to the amino-ter- 
minal 25 residues of cytochrome oxidase subunit IV 
(pCoxIV), and lipid model membranes of varying com- 
positions. This presequence is able to import attached 
proteins into mitochondria [5,6] and its interaction with 
model membranes is very well documented [3,20,22- 
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24,311. Moreover, these interactions were shown to be 
enhanced by a membrane potential [3,24]. 
We report here a novel property of the presequence: 
it induces cardiolipin (CL)-dependent interbilayer con- 
tacts, which can be reversed upon induction of a trans- 
membrane potential (negative inside). The significance 
of these observations for the mitochondrial import 
process is indicated. 
2. MATERIALS AND METHODS 
Cardiohpin from bovine heart. 1,2-dioleoyl-sn-glycero-3-phosphos- 
erine (DOPS), 1,2-dioleoyl-sn-glycero-3-phosphoglycerol (DOPG). 
and 1,2-dioleoyl-sn-giycero-3-phosphate (DOPA) were purchased 
from Avanti Polar Lipids. Inc. (Birmingham, AL). 1,2-Dioleoyl-sn- 
glycero-3-phosphochohne (DOPC) was synthesized as described [32]. 
Cardiohpin from E coli (strain AH930) was isolated and purified as 
will be described elsewhere (Killian et al.. manuscrtpt in preparation). 
Phosphattdylmositol (PI) from soybeans was obtained from Larodan 
Fine Chemicals AB (Malmo, Sweden). 
Large unilamellar vesicles (LUVs) were prepared at 10 mM phos- 
pholipid concentration in 150 mM K$O,, 20 mM HEPES (pH 7 0). 
2 mM EDTA (K’-buffer) by the extrusion technique [33], after 10 
times freezing and thawing, using 400 nm polycarbonate filters. Ion 
gradients were applied to the vesicles by replacing the external K’- 
buffer by Na’-buffer by passing the LUVs through a Sephadex G 50 
mintcolumn (1 ml) [33], eluted with 150 mM Na,SO,. 20 mM HEPES 
(pH 7.0). 2 mM EDTA (Na’-buffer). Concentrations of phosphorous 
were determined according to Rouser et al. [34]. CL concentrations 
are always given as phosphorous concentration. A membrane poten- 
tial was induced by adding valinomycm (Boehringer, Mannheim. Ger- 
many; 10 ,@ml in ethanol), to a 1:104 molar ratio with respect to 
phospholipid. to the LUVs exhibiting a K+,“/Na+,,, ion gradient. 
When required, vahnomycm and the uncoupler carbonylcyanide-p- 
trifluoromethoxyphenylhydrazone (FCCP; Sigma, St. LOUIS, MO; IO 
pg/ml m ethanol), whrch was added in a 1:8,103 molar ratto with 
respect to phospholipid, were added to the LUVs in order to investi- 
gate the influence of the pH gradient resulting from the membrane 
potential in the observed effects [35]. Transmembrane Na’,,/K’,,, 
gradients were applied by diluting LUVs prepared m Na’-buffer into 
K’-buffer. 
The presequence of yeast cytochrome oxidase subunit IV 
(H,N+MLSLRQSIRFFKPATRTLCSSRYLLCOO-) was prepared 
by solid phase synthesis by Mr. D. Olshevskt (University of California, 
San Diego) and purified as described [24] The identity of the peptide 
was confirmed by analysis of the amino acid composition and se- 
quence. Peptide solutions (1 mM in water) were always freshly pre- 
pared; concentration was determined according to Lowry et al [36]. 
The presequence was preincubated with 2% B-mercaptoethanol for 15 
min to reduce dtmer forms of the peptide. 
The turbidity of the vesicle solutions was measured as the absorb- 
ance at 400 nm on a Hitachi U-3200 spectrophotometer. The experi- 
ments were carried out under contmuous stirring at room tempera- 
ture, using a 1 ml quartz cuvette with a light path length of 1 cm. All 
experiments were carried out at least two times and the standard 
deviations in all turbidity changes were less than 10%. 
The presence of a membrane potential (negative inside) upon addt- 
tion of vahnomycin to vesicles, experiencing a K+,,/Na+,,, ion gradi- 
ent. was established using 3,3’-diethylthiadicarbocyamine iodide (dtS- 
C2-(S). Molecular Probes, Inc., Eugene, OR) as a membrane potential- 
sensitive fluorescent dye [37]. The presence of a membrane potential 
(positive inside) upon addition of valinomycin to LUVs with a Na’,,I 
K’,“, ion gradient, was established by monitormg (3-propyl-5-oxoi- 
soxazol-4-yl) pentamethine oxonol (oxonol VI. Molecular Probes, 
Inc., Eugene, OR) absorbance upon generation of the potential [38]. 
Under the experimental conditions employed, the addition of the 
presequence did not collapse the membrane potential (data not 
shown). 
3. RESULTS AND DISCUSSION 
In order to study the formation of interbilayer con- 
tacts, we analyzed the influence of the presequence on 
the turbidity of a solution of large unilamellar lipid 
vesicles. If such contacts are formed, the vesicle aggre- 
gates give rise to increased lightscattering, which can be 
measured as an increased absorbance. In this system the 
effect of a membrane potential can be studied by ap- 
plying valinomycin to LUVs with a K+,,/Na+,,, ion 
gradient. 
Fig. 1 shows a typical experiment with LUVs of 30% 
CL and 70% PC, without or with a K+,“/Na+,,, ion 
gradient. At t = 0, presequence was added to the solu- 
tions, resulting in both cases in a dramatic and rapid 
increase in turbidity. Without vesicles the presequence 
had no effect on the absorbance. The increased turbidity 
reveals the formation of larger sized structures. In prin- 
ciple this could be due to both vesicle aggregation and 
fusion, which were both reported by Roise et al. [3], who 
showed by electronmicroscopy in a similar system mas- 
sive aggregation and increase in the size of vesicles. 
Four minutes after presequence addition, the turbid- 
ity level had nearly reached equilibrium (Fig. 1). At this 
moment, a membrane potential was induced by addi- 
tion of valinomycin to the LUVs with a K’,,/Na+,,, ion 
gradient (curve b). This gave rise to a rapid decrease in 
turbidity up to about 80% of the total increase. In the 
control situation, where no membrane potential could 
be induced (curve a), valinomycin had no effect on the 
turbidity of the solution showing that the membrane 
potential, and not valinomycin itself, caused the de- 
crease in turbidity. If, together with valinomycin FCCP 
was added to the LUVs with a K+,,/Na’,,, ion gradient, 
the resulting turbidity decrease was the same as when 
only valinomycin was added (not shown), indicating 
that the turbidity decrease is caused by AY, and not by 
the pH gradient which is induced by AY [35]. The revers- 
ibility of the process indicates that the observed turbid- 
ity increase is, for at least 80%. due to vesicle aggrega- 
tion and not to presequence-induced vesicle fusion. If 
valinomycin was added to the vesicles prior to prese- 
quence addition, there was a rapid turbidity increase, 
until a level lower than in the reverse experiment, be- 
cause it was followed almost immediately by a decrease 
to approximately the same final level as in the reverse 
experiment, demonstrating the transient formation of 
interbilayer contacts in the presence of AY. A mem- 
brane potential with the opposite direction (positive in- 
side) was not able to reverse the presequence-induced 
turbidity increase, as was revealed by employing valino- 
mycin to LUVs with a Na’,,/K’,,, ion gradient (not 
shown). 
Fig. 2 shows the turbidity increase caused by addition 
of different amounts of presequence to LUVs. A thresh- 
old amount of presequence (corresponding to a peptide/ 
lipid molar ratio of about 0.012) is required to give a 
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Fig. 1. Presequence-mduced turbidity changes. At 1= 0. lO,uM prese- 
quence IS added to 300 PM DOPClbovine heart CL (713 molar ratio) 
LUVs. At the arrow valmomycin IS added to the vesicles (1: 10“ molar 
ratio with respect o total phospholipid) exhibitmg a K’,,/K’,,, (a) or 
a K’,, /Na’,,, ionic drstrtbutton (b). 
detectable turbidity increase. Above a peptideilipid 
ratio of approximately 0.025 the turbidity increases with 
the peptide /lipid ratio. 
The interbilayer contact formation and the reversibil- 
ity of the process were found to require the presence of 
bovine heart CL in the vesicles (Fig. 3). With 100% PC 
LUVs, no turbidity increase could be observed, even up 
to a peptidellipid ratio of 0.08 (not shown}. The pres- 
ence of only 10% CL already gave rise to a presequence 
induced turbidity increase of the vesicle solution. In this 
respect it is important to notice that the mitochondrial 
membranes contain about 20% CL [39]. With higher 
contents of CL in the LUVs. the turbidity increase. 
caused by the presequence. was greater and approached 
a saturation level at approximately 30% CL (Fig. 3A). 
Parallel to this turbidity increase, the turbidity decrease 
after addition of valinomycin was larger with higher CL 
contents in the vesicles (Fig. 3B). The total turbidity 
decrease after induction of the membrane potential var- 
ied from 65% (10% CL) up to 95% (50% CL) of the total 
turbidity increase. Not only the total turbidity increase 
and decrease were affected, but also the initial rates of 
the turbidity changes, after the addition of presequence 
and valinomycin, respectively, were increased with 
higher CL content in the vesicles (data not shown). 
To address the question whether the observed effects 
were specific for mitochondrial CL, a phospholipid 
which in the eukaryotic cell is only found in mitochon- 
dria [40], different negatively charged phospholipids 
were incorporated in PC vesicles, and the resulting tur- 
bidity increase and decrease upon addition of prese- 
quence and valinomycin, respectively, were compared 
to bovine heart CL-containing vesicles. The different 
negatively charged phospholipids that were examined 
are: DOPS, DOPG, DOPA, soybean PI, and E. co/i CL. 
Presequence was added to LUVs. containing 20% nega- 
0.2 
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I 
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Ftg. 3. Dependence of the presequence-induced turbidity increase of 
LUVs on the peptrde to lipid ratio. Different amounts of presequence 
were added to 300 PM DOPCibovine heart CL (713 molar ratio) 
LUVs. The turbidity increase 2 min after presequence addition IS 
plotted against the pepttde/liptd ratio. 
tively charged phospholipid and 80% DOPC, exhibiting 
a K’,,/Na’,,, ion gradient. The resulting turbidity in- 
creases are shown in Fig. 4 (closed bars}. No substantial 
turbidity increase could be observed for LUVs contain- 
ing PI. PS or PG. This is very remarkable because in 
previous monolayer and conformational studies. no sig- 
nificant differences were observed between PG and CL 
in interaction with pCoxIV [20,23], demonstrating a 
unique lipid specificity in interbilayer contact forma- 
tion. With CL from E. roll, only 40% of the effect which 
was obtained with CL from bovine heart was found. 
Vesicles containing PA gave the largest turbidity in- 
crease. However, when a membrane potential was in- 
duced upon addition of valinomycin, a decrease in tur- 
bidity (Fig. 4, open bars) could only be detected for the 
CL-containing vesicles, and hardly any decrease was 
observed for the vesicles containing DOPA. This sug- 
gests a different nature of the turbidity increase, for 
instance a more fusion-like. and thus irreversible, tur- 
bidity increase with the PA-containing vesicles. Alterna- 
tively, the membrane potential is not able to induce the 
same changes in the peptide-lipid aggregates as it does 
with the cardiolipin-containing vesicles. 
The results obtained in the current study demonstrate 
the novel property of a mitochondrial presequence 
being able to induce interbilayer contacts, which can be 
reversed by the membrane potential. It is unclear how 
the interbilayer contacts are induced, but several mech- 
anisms are possible, involving hydrophobic and hydro- 
philic interactions of the amphipathic presequence with 
the vesicles. Taking into account the direction of the 
potential (negative inside), the effect of dY can be ex- 
plained by a deeper insertion of the positively charged 
presequence into the bilayer. such that the contact with 
the opposing bilayer is lost. Most remarkable is the 
striking specificity in the observed effects for mitochon- 
drial CL. No other negatively charged phospholipids 
174 
Volume 327, number 2 FEBS LETTERS July 1993 
A 
0 10 20 30 40 50 60 
CL (mol% P) 
0 10 20 30 40 50 60 
CL (mol% P) 
Fig. 3. The turbidity changes of LUVs of PC/CL, induced by the 
presequence and a membrane potential, are dependent on the CL 
content in the LUVs. The turbidity increase 2 min after addition of 
10 PM presequence to 300 PM DOPC/bovine heart CL LUVs. exhib- 
iting a K+,,/Na+,,, ion gradient (A), and the turbidity decrease 3 min 
after valinomycin addition (B) are plotted against the CL content in 
the LUVs. 
caused the same effects as bovine heart CL. Since the 
CL from E. coli gives only about 40% of the effect of 
the mitochondrial CL, the fatty acid composition plays 
a role in the formation of the interbilayer contacts. The 
fatty acid composition of bovine heart CL is unique in 
that it contains about 85% linoleic acid (18:2) [41] and 
therefore is much more unsaturated than E. coli CL 
(about 70% fully saturated; Killian et al., manuscript in 
preparation). A higher degree of unsaturation leads to 
a greater tendency to form aggregate structures with 
concave interfaces, such as the inverted Hi, phase [42]. 
Such Hi, phases can, among others, be induced by pep- 
tides [43]. For instance melittin, like pCoxIV, a posi- 
tively charged amphiphilic peptide that forms an a-helix 
upon interaction with lipids, induces a H,,-phase in CL 
systems as a result of the deep penetration of the peptide 
inbetween the acyl chains [44,45]. Local formation of 
inverted non-bilayer structures have been proposed to 
play a role in intermembrane contact formation and 
protein transport [46]. It can be envisaged that the pre- 
sequence bridges two bilayers by creating a local point 
_- 
Fig. 4. Lipid specificity of the presequence and membrane potential 
modulated turbidity changes. LUVs were made of 80 mol% DOPC 
and 20 mol% negatively charged phospholipid. The different nega- 
tively charged phospholipids that were examined are: bovine heart CL 
(BHCL). E. colz CL (ECCL), soy bean PI, DOPS, DOPG and DOPA. 
The turbidity increase of 300 PM LUVs. exhibiting a K+,n/Natou, ion 
gradient, 2 mm after addition of 10 PM presequence, is given for the 
different negatively charged phosphohptds contaming LUVs (closed 
bars). The turbidity decrease 3 min after induction of a membrane 
potential is given as the open bars for the different negatively charged 
phosphohpid-containing LUVs. 
semifusion contact between the opposing monolayers. 
which can be dissociated by the membrane potential 
because it pulls the presequence out of the contact area. 
The fact that biological concentrations of CL in the 
vesicles is sufficient for the observed effects makes it 
interesting to speculate about the relevance for the mito- 
chondrial import process. Our new finding of the prese- 
quence-induced CL-specific interbilayer contact forma- 
tion supports the view that specific phospholipids play 
a role in the mitochondrial protein translocation proc- 
ess [47,48]. Previous studies demonstrated that CL par- 
ticipates, directly or indirectly, in the translocation of 
precursor proteins into mitochondria [47], and it was 
shown that the precursor proteins of P-450 (SCC), 
adrenodoxin and malate dehydrogenase have specific 
affinities for CL, which was due to presequenceecardi- 
olipin interactions [48]. We argue yet another role for 
specific phospholipids in the import process. We pro- 
pose that the presequence is involved in the formation 
and dissociation of mitochondrial contact sites. This 
proposal is supported by the growing evidence that con- 
tact sites are very dynamic structures [27-30,491. More- 
over, it has been demonstrated that CL is present in 
both mitochondrial membranes [39] and is enriched in 
the contact sites [50,51]. Our observations could be ex- 
plained in terms of a model in which the presequence 
of a precursor protein, that is being imported into mito- 
chondria, when it emerges from the outer membrane 
attaches to the inner membrane, thereby creating an 
intermembrane contact. After this contact has been 
formed the membrane potential across the inner mito- 
chondrial membrane can act on the presequence. result- 
ing in the subsequent translocation of the presequence 
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across the inner membrane. This A!#’ dependent translo- 
cation of the presequence could contribute to a dissoci- 
ation of the inner and outer membrane contact. 
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